Literature DB >> 25192743

Snowball: resampling combined with distance-based regression to discover transcriptional consequences of a driver mutation.

Yaomin Xu1, Xingyi Guo2, Jiayang Sun2, Zhongming Zhao1.   

Abstract

MOTIVATION: Large-scale cancer genomic studies, such as The Cancer Genome Atlas (TCGA), have profiled multidimensional genomic data, including mutation and expression profiles on a variety of cancer cell types, to uncover the molecular mechanism of cancerogenesis. More than a hundred driver mutations have been characterized that confer the advantage of cell growth. However, how driver mutations regulate the transcriptome to affect cellular functions remains largely unexplored. Differential analysis of gene expression relative to a driver mutation on patient samples could provide us with new insights in understanding driver mutation dysregulation in tumor genome and developing personalized treatment strategies.
RESULTS: Here, we introduce the Snowball approach as a highly sensitive statistical analysis method to identify transcriptional signatures that are affected by a recurrent driver mutation. Snowball utilizes a resampling-based approach and combines a distance-based regression framework to assign a robust ranking index of genes based on their aggregated association with the presence of the mutation, and further selects the top significant genes for downstream data analyses or experiments. In our application of the Snowball approach to both synthesized and TCGA data, we demonstrated that it outperforms the standard methods and provides more accurate inferences to the functional effects and transcriptional dysregulation of driver mutations.
AVAILABILITY AND IMPLEMENTATION: R package and source code are available from CRAN at http://cran.r-project.org/web/packages/DESnowball, and also available at http://bioinfo.mc.vanderbilt.edu/DESnowball/.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25192743      PMCID: PMC4271146          DOI: 10.1093/bioinformatics/btu603

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  40 in total

1.  ROCR: visualizing classifier performance in R.

Authors:  Tobias Sing; Oliver Sander; Niko Beerenwinkel; Thomas Lengauer
Journal:  Bioinformatics       Date:  2005-08-11       Impact factor: 6.937

Review 2.  The roles of IFN gamma in protection against tumor development and cancer immunoediting.

Authors:  Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Cytokine Growth Factor Rev       Date:  2002-04       Impact factor: 7.638

3.  Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.

Authors:  Levi A Garraway; Hans R Widlund; Mark A Rubin; Gad Getz; Aaron J Berger; Sridhar Ramaswamy; Rameen Beroukhim; Danny A Milner; Scott R Granter; Jinyan Du; Charles Lee; Stephan N Wagner; Cheng Li; Todd R Golub; David L Rimm; Matthew L Meyerson; David E Fisher; William R Sellers
Journal:  Nature       Date:  2005-07-07       Impact factor: 49.962

4.  Computational approaches to identify functional genetic variants in cancer genomes.

Authors:  Abel Gonzalez-Perez; Ville Mustonen; Boris Reva; Graham R S Ritchie; Pau Creixell; Rachel Karchin; Miguel Vazquez; J Lynn Fink; Karin S Kassahn; John V Pearson; Gary D Bader; Paul C Boutros; Lakshmi Muthuswamy; B F Francis Ouellette; Jüri Reimand; Rune Linding; Tatsuhiro Shibata; Alfonso Valencia; Adam Butler; Serge Dronov; Paul Flicek; Nick B Shannon; Hannah Carter; Li Ding; Chris Sander; Josh M Stuart; Lincoln D Stein; Nuria Lopez-Bigas
Journal:  Nat Methods       Date:  2013-08       Impact factor: 28.547

5.  Thrombospondin-1 expression in melanoma is blocked by methylation and targeted reversal by 5-Aza-deoxycytidine suppresses angiogenesis.

Authors:  Daniel J Lindner; Yan Wu; Rebecca Haney; Barbara S Jacobs; John P Fruehauf; Ralph Tuthill; Ernest C Borden
Journal:  Matrix Biol       Date:  2012-11-30       Impact factor: 11.583

6.  Evidence for an aryl hydrocarbon receptor-mediated cytochrome p450 autoregulatory pathway.

Authors:  Christopher R Chiaro; Rushang D Patel; Craig B Marcus; Gary H Perdew
Journal:  Mol Pharmacol       Date:  2007-08-24       Impact factor: 4.436

7.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

8.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.

Authors:  Mark D Robinson; Davis J McCarthy; Gordon K Smyth
Journal:  Bioinformatics       Date:  2009-11-11       Impact factor: 6.937

9.  PARADIGM-SHIFT predicts the function of mutations in multiple cancers using pathway impact analysis.

Authors:  Sam Ng; Eric A Collisson; Artem Sokolov; Theodore Goldstein; Abel Gonzalez-Perez; Nuria Lopez-Bigas; Christopher Benz; David Haussler; Joshua M Stuart
Journal:  Bioinformatics       Date:  2012-09-15       Impact factor: 6.937

10.  Tumor necrosis factor-α and apoptosis induction in melanoma cells through histone modification by 3-deazaneplanocin A.

Authors:  Ryo Tanaka; Nicholas C Donovan; Qiang Yu; Reiko F Irie; Dave S B Hoon
Journal:  J Invest Dermatol       Date:  2013-11-13       Impact factor: 8.551

View more
  2 in total

1.  In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAFV600E in melanoma.

Authors:  Xingyi Guo; Yaomin Xu; Zhongming Zhao
Journal:  Mol Cancer       Date:  2015-03-14       Impact factor: 27.401

2.  An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC).

Authors:  Yuanyuan Wang; Xingyi Guo; Michael J Bray; Zhiyong Ding; Zhongming Zhao
Journal:  BMC Genomics       Date:  2016-08-22       Impact factor: 3.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.